Determination of the spectrum of β-thalassemia genes in Spain by use of dot-blot analysis of amplified β-globin DNA

S. Amselem, V. Nunes, M. Vidaud, Xavier P. Estivill, C. Wong, L. d'Auriol, D. Vidaud, F. Galibert, M. Baiget, M. Goossens

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

We have delineated the molecular lesions causing β-thalassemia in Spain, a country that has witnessed the passage of different Mediterranean populations over the centuries, in order to evaluate the extent of heterogeneity of these mutations and to make possible simplified prenatal diagnosis of the disorder in that country. The use of the polymerase chain-reaction (PCR) technique to preferentially amplify β-globin DNA sequences that contain the most frequent β-thalassemia mutations in Mediterraneans enabled us to rapidly analyze 58 β-thalassemia alleles in a dot-blot format either by hybridization with allele-specific radiolabeled oligonucleotide probes or by direct sequence analysis of the amplification product. The Spanish population carries seven different β-thalassemia mutations; the nonsense codon 39 is predominant (64%), whereas the IVS1 position 110 mutation, the most common cause of β-thalassemia in the eastern part of the Mediterranean basin, is underrepresented (8.5%). The IVS1 mutation at position 6 accounts for 15% of the defects and leads to a more severe form of β+-thalassemia than originally described in most of the patients we studied. In this study, we demonstrate further the usefulness of the dot-blot hybridization of PCR-amplified genomic DNA in both rapid population surveys and prenatal diagnosis of β-thalassemia.

Original languageEnglish
Pages (from-to)95-100
Number of pages6
JournalAmerican Journal of Human Genetics
Volume43
Issue number1
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Thalassemia
Globins
Spain
DNA
Genes
Mutation
Prenatal Diagnosis
Alleles
Population
Polymerase Chain Reaction
Oligonucleotide Probes
Nonsense Codon
Sequence Analysis

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Determination of the spectrum of β-thalassemia genes in Spain by use of dot-blot analysis of amplified β-globin DNA. / Amselem, S.; Nunes, V.; Vidaud, M.; Estivill, Xavier P.; Wong, C.; d'Auriol, L.; Vidaud, D.; Galibert, F.; Baiget, M.; Goossens, M.

In: American Journal of Human Genetics, Vol. 43, No. 1, 1988, p. 95-100.

Research output: Contribution to journalArticle

Amselem, S, Nunes, V, Vidaud, M, Estivill, XP, Wong, C, d'Auriol, L, Vidaud, D, Galibert, F, Baiget, M & Goossens, M 1988, 'Determination of the spectrum of β-thalassemia genes in Spain by use of dot-blot analysis of amplified β-globin DNA', American Journal of Human Genetics, vol. 43, no. 1, pp. 95-100.
Amselem, S. ; Nunes, V. ; Vidaud, M. ; Estivill, Xavier P. ; Wong, C. ; d'Auriol, L. ; Vidaud, D. ; Galibert, F. ; Baiget, M. ; Goossens, M. / Determination of the spectrum of β-thalassemia genes in Spain by use of dot-blot analysis of amplified β-globin DNA. In: American Journal of Human Genetics. 1988 ; Vol. 43, No. 1. pp. 95-100.
@article{cd68abb6a6b14b0e91acc65be6ec1b1c,
title = "Determination of the spectrum of β-thalassemia genes in Spain by use of dot-blot analysis of amplified β-globin DNA",
abstract = "We have delineated the molecular lesions causing β-thalassemia in Spain, a country that has witnessed the passage of different Mediterranean populations over the centuries, in order to evaluate the extent of heterogeneity of these mutations and to make possible simplified prenatal diagnosis of the disorder in that country. The use of the polymerase chain-reaction (PCR) technique to preferentially amplify β-globin DNA sequences that contain the most frequent β-thalassemia mutations in Mediterraneans enabled us to rapidly analyze 58 β-thalassemia alleles in a dot-blot format either by hybridization with allele-specific radiolabeled oligonucleotide probes or by direct sequence analysis of the amplification product. The Spanish population carries seven different β-thalassemia mutations; the nonsense codon 39 is predominant (64{\%}), whereas the IVS1 position 110 mutation, the most common cause of β-thalassemia in the eastern part of the Mediterranean basin, is underrepresented (8.5{\%}). The IVS1 mutation at position 6 accounts for 15{\%} of the defects and leads to a more severe form of β+-thalassemia than originally described in most of the patients we studied. In this study, we demonstrate further the usefulness of the dot-blot hybridization of PCR-amplified genomic DNA in both rapid population surveys and prenatal diagnosis of β-thalassemia.",
author = "S. Amselem and V. Nunes and M. Vidaud and Estivill, {Xavier P.} and C. Wong and L. d'Auriol and D. Vidaud and F. Galibert and M. Baiget and M. Goossens",
year = "1988",
language = "English",
volume = "43",
pages = "95--100",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Determination of the spectrum of β-thalassemia genes in Spain by use of dot-blot analysis of amplified β-globin DNA

AU - Amselem, S.

AU - Nunes, V.

AU - Vidaud, M.

AU - Estivill, Xavier P.

AU - Wong, C.

AU - d'Auriol, L.

AU - Vidaud, D.

AU - Galibert, F.

AU - Baiget, M.

AU - Goossens, M.

PY - 1988

Y1 - 1988

N2 - We have delineated the molecular lesions causing β-thalassemia in Spain, a country that has witnessed the passage of different Mediterranean populations over the centuries, in order to evaluate the extent of heterogeneity of these mutations and to make possible simplified prenatal diagnosis of the disorder in that country. The use of the polymerase chain-reaction (PCR) technique to preferentially amplify β-globin DNA sequences that contain the most frequent β-thalassemia mutations in Mediterraneans enabled us to rapidly analyze 58 β-thalassemia alleles in a dot-blot format either by hybridization with allele-specific radiolabeled oligonucleotide probes or by direct sequence analysis of the amplification product. The Spanish population carries seven different β-thalassemia mutations; the nonsense codon 39 is predominant (64%), whereas the IVS1 position 110 mutation, the most common cause of β-thalassemia in the eastern part of the Mediterranean basin, is underrepresented (8.5%). The IVS1 mutation at position 6 accounts for 15% of the defects and leads to a more severe form of β+-thalassemia than originally described in most of the patients we studied. In this study, we demonstrate further the usefulness of the dot-blot hybridization of PCR-amplified genomic DNA in both rapid population surveys and prenatal diagnosis of β-thalassemia.

AB - We have delineated the molecular lesions causing β-thalassemia in Spain, a country that has witnessed the passage of different Mediterranean populations over the centuries, in order to evaluate the extent of heterogeneity of these mutations and to make possible simplified prenatal diagnosis of the disorder in that country. The use of the polymerase chain-reaction (PCR) technique to preferentially amplify β-globin DNA sequences that contain the most frequent β-thalassemia mutations in Mediterraneans enabled us to rapidly analyze 58 β-thalassemia alleles in a dot-blot format either by hybridization with allele-specific radiolabeled oligonucleotide probes or by direct sequence analysis of the amplification product. The Spanish population carries seven different β-thalassemia mutations; the nonsense codon 39 is predominant (64%), whereas the IVS1 position 110 mutation, the most common cause of β-thalassemia in the eastern part of the Mediterranean basin, is underrepresented (8.5%). The IVS1 mutation at position 6 accounts for 15% of the defects and leads to a more severe form of β+-thalassemia than originally described in most of the patients we studied. In this study, we demonstrate further the usefulness of the dot-blot hybridization of PCR-amplified genomic DNA in both rapid population surveys and prenatal diagnosis of β-thalassemia.

UR - http://www.scopus.com/inward/record.url?scp=0023753296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023753296&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 95

EP - 100

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 1

ER -